PPARA and Cerebral ischemia: In vivo as well as in vitro studies confirmed that preventive treatment, administration during the acute phase as well as therapeutic application of PPARα agonists such as fenofibrate could decrease brain damage after cerebral ischemia (Ouk et al., 2009, 2014; Gautier et al., 2015).